The abstract describes STING's role in I/RI across multiple organs but doesn't explain the mechanistic basis for how STING signaling contributes to tissue damage. Understanding these organ-specific mechanisms is crucial for developing targeted therapeutic interventions that could modulate STING activity appropriately. Gap type: unexplained_observation Source paper: Stimulator of interferon genes (STING): Key therapeutic targets in ischemia/reperfusion injury. (None, None, PMID:37699319)
Landscape Summary: What are the specific molecular mechanisms by which STING activation leads to I/RI damage versus protection in different organs? is a 0.8 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the specific molecular mechanisms by which STING activation leads to I/RI damage versus protection in different organs? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: